Expanding Oral Options in Psoriasis: Icotrokinra and Beyond
Please check back later for more content.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
2
Tremfya Meets Primary, Major Secondary Endpoints in Phase 4 STAR Study of Axial PsA
3
Alopecia Areata Awareness Month: 2026 in Review
4
From Mechanism to Management: Navigating Male Pattern Hair Loss and New Topical Therapies
5